title: Nonsevere community-acquired pneumonia: correlation between cause and severity or comorbidity.
abstract: BACKGROUND
  Community-acquired pneumonia frequently constitutes a nonsevere infection manageable at home. However, for these low-risk episodes, the epidemiological features have not been carefully analyzed.
  
  
  OBJECTIVE
  To determine the cause of nonsevere community-acquired pneumonia and to investigate if a correlation exists between cause and severity or comorbidity.
  
  
  METHODS
  During a 3-year period, all patients with nonsevere community-acquired pneumonia, according to the Pneumonia Patient Outcome Research Team prognostic classification (patients in groups 1-3), were included in the study. Causes were investigated through the following procedures: cultures of blood, sputum, and pleural fluid; serologic tests; and polymerase chain reaction methods to detect Streptococcus pneumoniae DNA in whole blood or Mycoplasma pneumoniae and Chlamydia pneumoniae DNA in throat swab specimens.
  
  
  RESULTS
  Of 317 initially included patients, 247 were eligible for the study. A microbial diagnosis was obtained in 162 patients (66%), and the main pathogens detected were S pneumoniae (69 patients [28%]), M pneumoniae (40 patients [16%]), and C pneumoniae (28 patients [11%]). For the 58 patients in prognostic group 1, M pneumoniae was the most prevalent cause, and atypical microorganisms constituted 40 (69%) of the isolated agents. In contrast, for patients in prognostic groups 2 and 3, S pneumoniae was the leading agent, and a significant reduction of M pneumoniae cases and a greater presence of other more uncommon pathogens were observed. The existence of comorbid conditions was not a determining factor for particular causes.
  
  
  CONCLUSIONS
  Among low-risk patients with community-acquired pneumonia, there was a certain correlation between severity and cause. In contrast, the existence of a comorbidity did not have a predictive causative value.
authors.affiliation: Department of Internal Medicine, Hospital Universitari Arnau de Vilanova, Rovira Roure 80, 25006 Lleida, Spain. mfalguera@comll.es
authors.forename: M
authors.initials: M
authors.lastname: Falguera
authors.forename: O
authors.initials: O
authors.lastname: Sacristán
authors.forename: A
authors.initials: A
authors.lastname: Nogués
authors.forename: A
authors.initials: A
authors.lastname: Ruiz-González
authors.forename: M
authors.initials: M
authors.lastname: García
authors.forename: A
authors.initials: A
authors.lastname: Manonelles
authors.forename: M
authors.initials: M
authors.lastname: Rubio-Caballero
mesh_terms: D000328:Adult; D000368:Aged; D023521:Chlamydophila Infections / Q000453:epidemiology; D016993:Chlamydophila pneumoniae / Q000302:isolation & purification; D017714:Community-Acquired Infections / Q000453:epidemiology / Q000382:microbiology; D015897:Comorbidity; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009177:Mycoplasma pneumoniae / Q000302:isolation & purification; D018410:Pneumonia, Bacterial / Q000453:epidemiology* / Q000382:microbiology*; D011019:Pneumonia, Mycoplasma / Q000453:epidemiology; D011018:Pneumonia, Pneumococcal / Q000453:epidemiology; D016133:Polymerase Chain Reaction; D011379:Prognosis; D012720:Severity of Illness Index; D013296:Streptococcus pneumoniae / Q000302:isolation & purification